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Abstract 
Objectives There is scant qualitative research into the experiences of tuberculosis treatment 
in urban risk groups with complex health and social needs in the UK. This study aimed to 
describe the social context of adherence to treatment in marginalised groups attending a major 
tuberculosis centre in London.  
Methods Qualitative cross-sectional study using semi-structured interviews with patients 
receiving treatment for tuberculosis.  Analytical frameworks aimed to reflect the role of 
broader social structures in shaping individual health actions.  
Results Seventeen participants, the majority were homeless and had complex medical and 
social needs including, drug and alcohol use or immigration problems affecting entitlement to 
social welfare. Participants rarely actively chose not to take their medication but described a 
number of social and institutional barriers to adherence and their need for practical support. 
Many struggled with the physical aspects of taking medication and the side effects. 
Participants receiving DOT reported both positive and negative experiences reflecting type of 
DOT provider and culture of the organisation. 
 
Conclusions There is a need for integrated care across drug, alcohol, HIV and homeless 
services in order to address complex clinical co-morbidities and social need which impact on 
patients’ ability to sustain a course of treatment. 
 
Keywords: Tuberculosis, social determinants, adherence, homeless persons, drug users, 
stigma 
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Background  
A recent cross-sectional survey of tuberculosis notification rates across the European Union 
(EU) reported that 15/54 cities had notification rates twice the national country rate with some 
cities experiencing rates 3-4 times the national level.1 These included: Birmingham and 
London (UK), Brussels (Belgium) and Rotterdam (the Netherlands). The authors attributed 
high rates of tuberculosis in major conurbations, in countries otherwise classified as having a 
low incidence of disease, to the high concentration of urban risk groups. This raises particular 
challenges for a national TB control programme.   
Cases of TB are over-represented in socially and economically marginalised groups in high 
income countries. In 2013 in the UK for example 70% of the TB caseload came from the 40% 
most deprived areas and 44% of TB cases did not have employment.2 Groups that are affected 
by TB in the UK include migrants from high TB endemic countries, homeless populations, 
prisoners, people living with HIV/AIDs (PLWHA) and  people who use drugs (PWUD) and 
alcohol.  These groups are at greater risk of TB than the general population. They also 
comprise: 38% of non-treatment adherent cases, 44% of cases lost to follow up, 30% of cases 
deemed highly infectious and represent approximately 17% of the London TB caseload.3 
Approximately 10% of the national caseload is characterised by at least one social risk factor 
associated with non-adherence including drug or alcohol abuse, homelessness and 
imprisonment (3.2%; 3.9%; 3.3%; 2.9% respectively).2 Failure to adhere to a prescribed 
course of treatment can result in the development of drug resistant disease which is more 
difficult and expensive to treat, serious morbidity and mortality and increased risk of 
transmission.4  
The World Health Organisation (WHO) has endorsed the use of supervised pill taking (DOT) 
as the standard of care to promote adherence although this has not been consistently applied 
in the UK context 3 with fewer than half of eligible patients receiving DOT in 2013.2  This can 
either be interpreted as a failure of services to upscale DOT or that some patients are 
perceived to be able to manage a course of treatment without DOT.  
Two reasons for non-adherence to medication have been theorised: unintentional non-
adherence (people intend to take medication but fail to do so in the correct way) or intentional 
non-adherence (people choose not to take medication).5 Criticism of the adherence literature 
has been the dominance of psychological approaches which over-emphasise individual 
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agency, particularly in marginalised populations where choice and control are most 
constrained.6,7  
Gaining a better understanding of how wider contextual factors impact on adherence is crucial 
if we aim to develop responsive services which address both clinical and social need. For 
example, the results of  two systematic, qualitative reviews concluded that adherence to 
tuberculosis treatment was dependent on a range of complex and  interrelated  factors, 
including: both personal and structural factors, the configuration of health services, and the 
social and economic context.8,9 The WHO adherence framework additionally emphasises 
therapy and condition related factors (e.g. side effects and co-morbidities).10  
In this study we aimed to contextualise the experiences of our participants within a social 
determinants of health framework11,12 to highlight how broader social structures shape 
individual health actions which give rise to intentional and unintentional non-adherence. We 
also aimed to identify examples of ‘resilience strategies’ that our participants adopted to 
manage their treatment.5 The study formed part of a wider service development project 
conducted in London, UK, which aimed to develop a social outreach model of care for 
marginalised groups with TB and generate an evidence base for the need of a TB caseworker 
in supporting clients with complex needs and is reported elsewhere.13,14  
Methods  
 
Recruitment: Participants in the interview study were recruited from a major TB centre 
characterised by a culturally diverse catchment area including migrant and homeless 
populations between 2003 and 2004.  Interviewees were selected for inclusion based on a risk 
assessment,14 completed by nurses, which identified those factors which could complicate 
adherence to treatment (e.g. drug use, homelessness, missed appointments) and the need for a 
referral to a caseworker for enhanced case management. Participants were referred to the 
researcher by nurses or case worker at different stages of their treatment. Sampling was 
broadly purposive and reflected a range of ‘critical case’ experiences typical of those 
presenting with complex needs and the caseworker’s caseload.15, 16  Participants were 
informed that the study was part of a new initiative developing a social outreach model of 
support.17 Interviews lasted between 30 and 60 minutes and covered broad based themes 
about experiences of treatment. The majority of interviews took place in the hospital 
outpatients’ clinic, three took place on a hospital ward, one interview took place in a homeless 
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hostel and one in a prison with the permission of managers. Clinic interpreters were used in 
two cases. Interviews generally coincided with patients’ appointments and they were offered a 
food voucher to the value of £5. Due to the difficulty of researching this group within a 
clinical environment (e.g. lack of private spaces, frequent interruptions) and because some 
patients experienced different social risks impacting on adherence later in their treatment (e.g. 
people became homeless or their immigration status changed affecting entitlements), 
participants were interviewed on more than one occasion. All interviews were audio recorded 
and transcribed verbatim, except for the two interviews involving interpreters and one in the 
prison. Here notes were taken.  
 
Analysis 
The analysis was informed by a critical health psychology perspective which understands 
illness behaviour within social, political and cultural contexts which not only influence health 
and illness, but health care organisation and delivery.18 We adopted a theoretical thematic 
analysis19 involving both deductive (top down) and inductive (bottom up) coding and linking 
codes drawing on the WHO adherence framework (ie. personal factors such as resilience, 
social and economic contexts, therapy and condition related factors and health care systems). 
Segments of relevant text relating to adherence and contextual information were identified 
and compared across transcripts. Analytic memos were used to aid analysis. Data analysis 
was managed using a computer software programme designed specifically for the coding and 
retrieval of qualitative data (QSR NUDIST*Vivo 10). Coding was compared and 
corroborated between researchers; one with a social science background and one with a 
background in nursing and homelessness.  
Ethical considerations and consent: This research was carried out within the guidelines of 
University College London Hospital’s Research Ethics Committee which approved the study. 
Written or verbal consent was obtained (as agreed with the ethics committee). Participants 
were advised that the interview did not form part of their clinical care. If the participant 
became tired or agitated the interviews were terminated and rescheduled. Where participants 
became distressed or disclosed distressing experiences, the researcher terminated the 
interview and offered a referral to the caseworker. 
 
Results and discussion 
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Participant characteristics and the wider context of adherence 
Seventeen participants were interviewed: sixteen with a confirmed diagnosis of TB and one 
with suspected tuberculosis. The majority of interviewees were male (71%; 12/17).  Just over 
half were born in the UK (59%; 9/17) and of these six described their ethnicity as White 
British. The remainder were: two of Irish origin; one Black British; two Black African; and, 
one woman who described herself as Jewish. Of those born outside the UK, two were 
Ethiopian and three Somalian. The mean age of respondents was 44 years (range 18-67; 
n=16) at the start of their initial treatment. Table 1 provides further details, including co-
morbidities and drug resistance. 
 
Income, housing and employment  
The majority of participants were homeless according to statutory legislation. Five 
participants had complex immigration cases affecting their entitlement to housing and 
welfare. Three became unemployed due to illness and were therefore left without an income. 
The remainder were in receipt of social welfare or voucher scheme (used in exchange for food 
in designated shops).   Participants described a range of measures to supplement their income 
including: sex work, begging, stealing to obtain food or drugs, reliance on food handouts, 
informal assistance from relatives, casual labour and community support.  
 
Drug and alcohol use 
Nine (53%) participants reported drug use including polydrug use. Seven participants were 
receiving opioid substitution therapy (OST, methadone maintenance) at the time of interview. 
PWUD also reported consuming alcohol, but to different degrees. Three other participants 
reported problematic alcohol use. Everyday routines were dominated by drug and alcohol 
consumption and for people who injected drugs (PWID), measures to finance their drug use 
and prevent drug withdrawal syndrome. 
 
Experiences of violence and social exclusion 
Many participants disclosed past experiences of violence, torture, physical and sexual abuse. 
Others spoke of lives dominated by a cycle of crime, including youth offending, drug use and 
imprisonment.  Their experiences were firmly embedded within narratives of violence and 
exclusion 20 and, in some cases, illustrated the cumulative effect of disadvantage impacting 
and constraining behavioural choices.10,11 
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Support  
Lack of social support from friends and family was a significant issue for many 
participants due to their migrant/refugee status or because they were estranged from 
their family. Few were able to identify people who offered support on a regular basis. 
Some family members were reported to provide financial support, but not emotional or 
practical aid. People who were homeless mostly had other homeless people in their 
social network that limited the type of support available. One person reported increased 
support from his family following a noticeable improvement in his condition (ID12). 
Another received support from a close friend who would ring him to remind him to take 
his medication (ID03). In general the participants were reliant on the TB clinic for 
support or hostel workers who would remind patients to take their medicines or 
accompany them to clinic appointments. However this was not always consistent as 
funding sources, and lack of training, often precluded assistance with health care. One 
man reported that hostel staff would not come to his room if he was too ill to get up:  
 
They don’t [check on you]. No. Because they say they are, it is not a nursing home 
(ID04) 
 
When asked about the type of support needed,  participants responded with reference to 
material or practical assistance such as finding a job, housing, money to buy ‘good’ food, 
assistance with shopping, coming off drugs and, someone to talk to.  
Disclosure and stigma  
An older Somali refugee described how she hid her diagnosis and her TB medication from the 
relatives she lived with, administering them in secret. Her fear of disclosure related to the 
threat of eviction and rejection by the wider Somali community resulting in a loss of material 
and social support: 
I keep medication in a secret place and take medication at a secret time. The other illness 
(diabetes) they (relatives) know about it and accept it.  The first thing I will lose is my 
accommodation and the relationship. My situation could then be communicated to other 
Somalians (ID07) 
Scambler 21 suggests the fear of negative reactions (felt stigma) can be more detrimental 
psychologically than the actual experience of discrimination (enacted stigma) because of the 
effort people expend when trying to conceal their condition. According to this theory people 
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become so adept at concealment as a first choice strategy that examples of enacted stigma are 
rare. Moreover the adverse effects of stigma may have a greater impact on women because of 
their (gendered) social location.22  Some participants reported that the disease was used as an 
excuse to shun or evict a person because of dislike (ID03) rather than stigma. Others noted 
social distancing (ID01), sympathy (ID05), indifference (ID02) and acceptance where family 
were able to witness the beneficial effects of treatment (ID12). 
 
Health Care Systems 
 
Hospital practice on methadone maintenance, drugs and alcohol consumption 
Although there are guidelines on OST to stabilise PWID while in hospital23 there was a 
perception that, along with other drugs obtained illicitly (eg.valium/diazepam), these were 
under-prescribed. The frequency of dosing, sometimes with long intervals due to delays in 
administering methadone, was such that some patients experienced withdrawal syndrome.24 
This was frightening where they felt they had little control illustrating the psychosocial 
aspects of withdrawal. Physicians may fear the consequences of over-prescribing methadone 
and the conflicts experienced between meeting the needs of patients and adhering to 
prescribing protocols, with the potential for impact on the therapeutic relationship, has been 
documented.25 
  
As some hospital wards operated a zero tolerance policy in relation to drug and alcohol use 
participants reported leaving the hospital to obtain drugs to cope. Some reported that staff, 
adopting a lenient approach, turned a blind eye to alcohol use off premises providing patients 
returned to the ward; a ‘compromise’ to encourage adherence to treatment plans. Consultants 
sometimes refused to treat patients unless they agreed to modify their behaviour. In extreme 
cases patients were coerced into complying with treatment in order to avoid compulsory 
detention.  
 
Hospitalisation as a safety net or welcome break 
In contrast to those who experienced drug withdrawal while in hospital, one homeless man 
was more able to tolerate the demands of hospitalisation which he viewed as a welcome break 
from the cold and months of homelessness living on the street: ‘it was like a bit of a holiday’ 
(ID05). As a methadone user with occasional heroin use, his daily routines were less 
dominated by drug use and withdrawal. 
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In some cases, interviewees experienced lengthy periods of hospitalisation for social reasons 
in addition to medical need. One young woman spent several months in hospital due to 
homelessness and a history of sexual exploitation (ID10). Despite having lived in the UK 
since a child, her immigration status precluded any recourse to public funds rendering her 
destitute. The doctors decided to delay discharge from the hospital because she was very 
young and vulnerable. She remained an in-patient for several months until the Social Services 
accepted they had a duty of care and provided accommodation allowing a safe-discharge and 
stable environment for her to complete her treatment.  
 
Directly Observed Therapy (DOT) 
Those patients receiving medicines through DOT (n=9) spoke of the benefits in terms of 
contact with ‘normal people’ and ‘female company’ (for some homeless men), support from 
staff and the structure the clinic visits afforded: ‘the day I’m not going to the clinic it’s 
difficult to get up. It’s my day out’ (ID01). 
 
For PWID DOT was provided at a number of locations including: the Drug Dependency Unit 
(DDU) or pharmacist in conjunction with methadone, the hostel via outreach workers or, the 
TB clinic. However DOT was not always successful even where the location or provider 
changed. PWID did not always attend the DDU, either because of the distance they had to 
travel, or because they had used or intended to obtain drugs. The monitoring of pill 
swallowing also varied across different healthcare locations; whereas some staff made distinct 
efforts to check that all pills had been swallowed, particularly where methadone was 
dispensed, others supervised at arm’s length “out of the corner of their eye”. There was 
however evidence of resentment where DOT was administered in an authoritarian 
atmosphere:   
 
I hated it. Um, (pause) I felt that, I was threatened, you know, it's like, if you didn't take this, 
then you couldn't have that I felt like I was at school. And, in the end I just wanted to say: 
**** the lot of you. Because I couldn't take the TB pills you know, my body did not want the 
pills any more, but, my body still needed the methadone. (ID15) 
 
Personal Factors  
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Experience of medication and resilience strategies 
For those participants not receiving DOT, a dominant theme was the way treatment regimens 
impacted on everyday routines, compounded by the number and size of tablets and frequency 
of dosing.26 A health care worker taking medication for both HIV and TB spoke of the day 
dominated by pills and the difficulty of taking the prescribed regimen when trying to maintain 
daily routines such as shopping. She took nine pills in the morning, seven at lunch time, three 
in the afternoon and seven at night. The only way to manage her regimen was to skip the 
afternoon dose: 
 
I've never missed my morning, drugs and my night drugs. But my afternoon drugs: yes. 
(ID08)  
 
This example illustrates the limitations of pill organisers when faced with the demands of the 
schedule of dosing. It wasn’t her memory that failed her; rather, the lack of practical support 
with her daily activities. Others appeared more able to incorporate tablets into their daily 
routines where pill taking already formed part of their everyday lives (e.g. pills for 
hypertension).  
 
The difficulty of combining medication with an itinerant lifestyle and the storage of 
medicines was a major problem. One homeless man had his bag stolen (ID05) and others 
reported difficulties carrying medicines with them such that where they had stored their 
medication was not where they ended up sleeping. Participants reported running out of 
medicines. The requirement to take medicines on an empty stomach, one hour before food, 
when some patients had little control over the availability of food in terms of supply or 
affordability was also a factor, particularly where they depended on ‘handouts’ provided by 
charities. Here food was prioritised over pill taking. Others radically changed their eating and 
sleeping patterns in order to take medication.27 One participant ensured that she didn’t eat 
anything after 3am in order to take her morning medication on an empty stomach. Another 
reported that he missed his medicines if looking for money to buy drugs or if taking heroin 
instead of methadone.  
 
Those with more routinised and stable lifestyles were able to manage their medicines and 
devised resilience strategies by creating reminders5 such as setting an alarm clock, or memory 
aid, in the form of a chart, to record pill taking. Others attempted to cut up or crush tablets 
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(although not medically recommended) or consume with nutrient drinks to avoid feeling sick. 
Modifying regimens rather than take medicines as prescribed has been described as 
‘purposeful non-adherence.’27  
The quality of reminder cues also varied and some were more vulnerable to failure as in the 
example of the homeless man who struggled to take his medication due to a combination of 
poor memory, tiredness, problems swallowing and alcohol use (ID02). He developed a 
routine which involved leaving his tablets in a place near to where he slept only to awake to 
find someone had moved them. 
Therapy related factors and co-morbidities 
Adverse effects of medicines   
Although much emphasis is placed on adherence to treatment, the adverse effects of therapy 
receive less attention.27 Some reported feeling nauseas or vomiting following their medicines 
(‘Most day I vomit after taking my medication’ (ID08)) which may have been due to the 
number of tablets, particularly where administered through thrice weekly DOT (ID14). 
Numbness and dizziness (D08) has also been reported in patients taking antiretrovirals.27 
Others described what appeared to be adverse drug reactions which caused them to interrupt 
their treatment. The side effects of isoniazid also include nausea, vomiting and numbness. 
Some PWUD found it difficult to distinguish between the symptoms of tuberculosis, other co-
morbidities and the adverse effects of medication: 
 
Feel better but can't remember feeling bad because so wrapped up in drugs and alcohol.  
Walking from the hostel to get methadone, I was sweating like mad. Can't remember if 
it was TB drugs, drink or combination. (ID01) 
 
Conversely another patient was able to attribute the cause of his symptoms specifically to TB 
medication because of withdrawal syndrome, reflecting the way rifampin reduces the effect of 
methadone.28  
The tablet’s, actually, [have] halved, the dosage of methadone. So instead of me 
being on a hundred and twenty five, I’m only getting sixty two and a half per cent in 
my body, because the pills are wiping out, the other sixty two and a half per cent. 
(ID14) 
His methadone was later increased to compensate. Alcohol consumption resulting in 
vomiting, diarrhoea or blackouts was also given as a reason for not taking medicines (ID16). 
Conclusions  
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Research has theorised two reasons for non-adherence: intentional and non-intentional. The 
results of this study has highlighted the structural and institutional contexts impacting on 
adherence to treatment.29  Drug and alcohol use was clearly a complicating factor as was 
homelessness but other factors included: the culture of services (e.g. perceived to be 
authoritarian or punitive); institutional policies (e.g. methadone prescribing practices and zero 
tolerance on drug and alcohol consumption resulting in withdrawal syndrome, patients 
leaving the hospital); lack of effective partnership working with homeless organisations or 
financial restrictions placed on those organisations by funders impacting on their ability to 
support patients); requirements to take medication in prescribed ways geared toward those 
with routinised lifestyles (e.g. in relation to mealtimes) or the adverse effects of therapy 
coupled with complex co-morbidities (resulting in nausea and vomiting). Those receiving 
DOT reported both positive and negative experiences relating to type of DOT provider and 
culture of the organisation. 
 
Participants appeared more able to sustain a course of treatment where their environment was 
stable and where they received support through friends, family community services or case 
worker which played an important role. Practical support was valued and has been found to 
support adherence in other conditions.30 Some participants showed evidence of quite 
sophisticated resilience strategies in managing their medication. 
 
A Cochrane review of research to promote adherence more generally31 identified 21 strategies 
which, with little exception (e.g. group meetings), focused on interventions at the individual 
patient level.  In our study however, people rarely actively ‘chose’ not to take their 
medication. Rather adherence to treatment involved a complex interplay of factors involving 
their social location, co-morbidities and service policy and delivery. Interventions that target 
individual coping skills therefore are unlikely to meet with success in marginalised 
populations, such as those described here, in the absence of measures which address the ‘risk 
environments’32 (e.g. homelessness) which render people vulnerable to both TB disease and 
non-adherence to treatment.  
 
Rather than view non-adherence as individual failure, a more productive approach would be 
for services to collectively share the responsibility for treatment adherence, and any 
associated risks, through the co-creation of localised, inter-sectoral, collaborative care 
pathways which integrate drug, alcohol and homeless services and which are able to address 
 13 
 
both clinical and social risks.17,33 This will require smarter approaches to commissioning joint 
health and social care services with implications for resourcing and workforce development.  
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Int ID Usual pattern of 
housing+ 
Place of birth Criminal justice Drug use OST Alcohol HIV+ Other self 
reported health 
conditions 
Drug 
resistant 
TB 
ID01 Hostel 
 
UK  PWID    Epilepsy 
 
INH  
ID02 NFA UK      Epilepsy 
 
 
ID03 Shared house 
(temporary) 
Ethiopia        
ID04 Bedsit 
Hostel 
Nigeria  PWUD    Diabetes 
 
INH 
ID05 NFA UK  PWID      
ID06 NFA UK  PWID      
ID07 B&B 
Staying with relatives in 
their house 
Somalia      Hypertension 
Diabetes 
Ulcer 
 
ID08 At risk as no recourse 
to public funds due to 
immigration status 
Nigeria      Drug induced 
diabetes 
 
 
ID09 NFA UK  PWID    Hepatitis C 
 
 
ID10 NFA 
Hostel 
Ethiopia        
ID11 NFA sometimes  
stays at a friend’s 
house 
UK      Stomach ulcers 
 
 
ID12 B&B Somalia        
ID13 NFA Ireland       Arthritis 
 
 
ID14 Hostel UK  PWID      
ID15 Temporary bedsit UK  PWID    Hepatitis 
 
 
ID16 Hostel UK  PWID     INH 
ID17 B&B Somalia       INH 
NFA= no fixed abode usually sleeping on streets; PWID person who injects drugs; PWUD person who uses drugs; OST Opioid substitution 
therapy (methadone); B&B an individual room to sleep where breakfast is sometimes offered. MXU mobile x-ray unit; DDU Drug 
dependency unit; INH Izoniazid; + did not have one main place of residence but would alternate;  
Table 1 Social characteristics of interviewees  
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